Forecasts data is unavailable for this security.
Consensus recommendation
- 18-Jul-24
- 17-Apr-25
- 15-May-25
- 19-Jun-25
- 17-Jul-25
Select bar for recommendation details.
Recommendations | 17-Jul-25 | |
---|---|---|
Buy | 3 | |
Outperform | 6 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 11 analysts offering 12 month price targets for Hikma Pharmaceuticals Plc have a median target of 2,561.13, with a high estimate of 3,101.53 and a low estimate of 2,100.48. The median estimate represents a 27.42% increase from the last price of 2,010.00.
High | 54.3% | 3,101.53 |
Med | 27.4% | 2,561.13 |
Low | 4.5% | 2,100.48 |
Dividends in USD
Div growth (TTM) | 5.95% |
---|
More ▼
Earnings history & estimates in USD
Average growth rate | +7.23% |
More ▼
Revenue history & estimates in USD
Average growth rate | +7.66% |
More ▼